60 Degrees Pharmaceuticals, Inc. (SXTPW) stock
SXTPWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3033% below fair value
$0.03−0.00 (-0.38%)
Close on Oct 30, 2026Market cap $3.31MP/E –Yield –
60 Degrees Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
60 Degrees Pharmaceuticals's price to sales ratio was 2.0× on Oct 19, 2026, against 3.1× a year earlier. Over the last 3 years it ranged from 1.7× to 10.0×, with a median of 3.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 2.0× | −0.2 |
| 2025 | Dec 31, 2025 | 2.2× | −2.7 |
| 2024 | Dec 31, 2024 | 4.9× | – |